Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Irvine, California, dedicated to advancing innovative therapeutic candidates specifically targeting ophthalmic diseases. With a pipeline centered around groundbreaking treatments for conditions such as dry eye disease and other vision-related disorders, Tarsus aims to fill significant unmet medical needs in the ophthalmic market. The company's commitment to robust clinical development supports its mission to enhance patient outcomes and drive long-term growth.